These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 37402060)

  • 1. Feasibility of home-based exercise training during adjuvant treatment for metastatic castrate-resistant prostate cancer patients treated with an androgen receptor pathway inhibitor (EXACT).
    Brown M; Murphy MH; McAneney H; McBride K; Crawford F; Cole A; O'Sullivan JM; Jain S; Prue G
    Support Care Cancer; 2023 Jul; 31(7):442. PubMed ID: 37402060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of home-based exercise training in men with metastatic castration-resistant prostate cancer.
    Hanson ED; Alzer M; Carver J; Stopforth CK; Lucas AR; Whang YE; Milowsky MI; Bartlett DB; Harrison MR; Bitting RL; Deal AM; Stoner L; Hackney AC; Battaglini CL
    Prostate Cancer Prostatic Dis; 2023 Jun; 26(2):302-308. PubMed ID: 35306542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility, safety, and acceptability of a remotely monitored exercise pilot CHAMP: A Clinical trial of High-intensity Aerobic and resistance exercise for Metastatic castrate-resistant Prostate cancer.
    Kenfield SA; Van Blarigan EL; Panchal N; Bang A; Zhang L; Graff RE; Chen YH; Ryan CJ; Luke A; Newton RU; Tenggara I; Schultz B; Wang E; Lavaki E; Zuniga K; Pinto N; Borno H; Aggarwal R; Friedlander T; Koshkin VS; Harzstark A; Small E; Chan JM
    Cancer Med; 2021 Nov; 10(22):8058-8070. PubMed ID: 34636156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise for advanced prostate cancer: a multicomponent, feasibility, trial protocol for men with metastatic castrate-resistant prostate cancer (EXACT).
    Brown M; Murphy M; McDermott L; McAneney H; O'Sullivan JM; Jain S; Prue G
    Pilot Feasibility Stud; 2019; 5():102. PubMed ID: 31428443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II randomized controlled trial of three exercise delivery methods in men with prostate cancer on androgen deprivation therapy.
    Alibhai SMH; Santa Mina D; Ritvo P; Tomlinson G; Sabiston C; Krahn M; Durbano S; Matthew A; Warde P; O'Neill M; Timilshina N; Segal R; Culos-Reed N
    BMC Cancer; 2019 Jan; 19(1):2. PubMed ID: 30606137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life for men with metastatic castrate-resistant prostate cancer participating in an aerobic and resistance exercise pilot intervention.
    Langlais CS; Chen YH; Van Blarigan EL; Chan JM; Ryan CJ; Zhang L; Borno HT; Newton RU; Luke A; Bang AS; Panchal N; Tenggara I; Schultz B; Lavaki E; Pinto N; Aggarwal R; Friedlander T; Koshkin VS; Harzstark AL; Small EJ; Kenfield SA
    Urol Oncol; 2023 Mar; 41(3):146.e1-146.e11. PubMed ID: 36528473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intense Exercise for Survival among Men with Metastatic Castrate-Resistant Prostate Cancer (INTERVAL-GAP4): a multicentre, randomised, controlled phase III study protocol.
    Newton RU; Kenfield SA; Hart NH; Chan JM; Courneya KS; Catto J; Finn SP; Greenwood R; Hughes DC; Mucci L; Plymate SR; Praet SFE; Guinan EM; Van Blarigan EL; Casey O; Buzza M; Gledhill S; Zhang L; Galvão DA; Ryan CJ; Saad F
    BMJ Open; 2018 May; 8(5):e022899. PubMed ID: 29764892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life after apalutamide treatment in patients with metastatic castration-sensitive prostate cancer (TITAN): a randomised, placebo-controlled, phase 3 study.
    Agarwal N; McQuarrie K; Bjartell A; Chowdhury S; Pereira de Santana Gomes AJ; Chung BH; Özgüroğlu M; Juárez Soto Á; Merseburger AS; Uemura H; Ye D; Given R; Cella D; Basch E; Miladinovic B; Dearden L; Deprince K; Naini V; Lopez-Gitlitz A; Chi KN;
    Lancet Oncol; 2019 Nov; 20(11):1518-1530. PubMed ID: 31578173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of aerobic- and resistance-emphasised exercise on cardiometabolic health and quality of life in men receiving androgen deprivation therapy for prostate cancer: Protocol for a feasibility trial.
    Murphy K; Kehoe B; Denieffe S; Hacking D; Fairman CM; Harrison M
    Contemp Clin Trials; 2024 Jan; 136():107388. PubMed ID: 37972755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protocol for a phase III RCT and economic analysis of two exercise delivery methods in men with PC on ADT.
    Alibhai SMH; Ritvo P; Santa Mina D; Sabiston C; Krahn M; Tomlinson G; Matthew A; Lukka H; Warde P; Durbano S; O'Neill M; Culos-Reed SN
    BMC Cancer; 2018 Oct; 18(1):1031. PubMed ID: 30352568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Home-based versus supervised group exercise in men with prostate cancer on androgen deprivation therapy: A randomized controlled trial and economic analysis.
    Alibhai SMH; Papadopoulos E; Mina DS; Ritvo P; Tomlinson G; Sabiston CM; Durbano S; Bremner KE; Chiarotto J; Matthew A; Warde P; O'Neill M; Culos-Reed SN
    J Geriatr Oncol; 2024 Jan; 15(1):101646. PubMed ID: 37976654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nutrition therapy with high intensity interval training to improve prostate cancer-related fatigue in men on androgen deprivation therapy: a study protocol.
    Baguley BJ; Skinner TL; Leveritt MD; Wright OR
    BMC Cancer; 2017 Jan; 17(1):1. PubMed ID: 28049525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Individualized Diet and Exercise Adherence Pilot Trial (IDEA-P) in prostate cancer patients undergoing androgen deprivation therapy: study protocol for a randomized controlled trial.
    Focht BC; Lucas AR; Grainger E; Simpson C; Thomas-Ahner JM; Clinton SK
    Trials; 2014 Sep; 15():354. PubMed ID: 25199619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II RCT and economic analysis of three exercise delivery methods in men with prostate cancer on androgen deprivation therapy.
    Alibhai SM; Santa Mina D; Ritvo P; Sabiston C; Krahn M; Tomlinson G; Matthew A; Segal R; Warde P; Durbano S; O'Neill M; Culos-Reed N
    BMC Cancer; 2015 Apr; 15():312. PubMed ID: 25908311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility and Safety of Physical Exercise to Preserve Bone Health in Men With Prostate Cancer Receiving Androgen Deprivation Therapy: A Systematic Review.
    Cagliari M; Bressi B; Bassi MC; Fugazzaro S; Prati G; Iotti C; Costi S
    Phys Ther; 2022 Mar; 102(3):. PubMed ID: 34972863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lifestyle changes for improving disease-specific quality of life in sedentary men on long-term androgen-deprivation therapy for advanced prostate cancer: a randomised controlled trial.
    Bourke L; Gilbert S; Hooper R; Steed LA; Joshi M; Catto JW; Saxton JM; Rosario DJ
    Eur Urol; 2014 May; 65(5):865-72. PubMed ID: 24119318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatigue, quality of life and metabolic changes in men treated with first-line enzalutamide versus abiraterone plus prednisolone for metastatic castration-resistant prostate cancer (HEAT): a randomised trial protocol.
    Kvorning Ternov K; Sønksen J; Fode M; Lindberg H; Kistorp CM; Bisbjerg R; Palapattu G; Østergren PB
    BMJ Open; 2019 Sep; 9(9):e030218. PubMed ID: 31511288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer Activity and Tolerance of Treatments Received Beyond Progression in Men Treated Upfront with Androgen Deprivation Therapy With or Without Docetaxel for Metastatic Castration-naïve Prostate Cancer in the GETUG-AFU 15 Phase 3 Trial.
    Lavaud P; Gravis G; Foulon S; Joly F; Oudard S; Priou F; Latorzeff I; Mourey L; Soulié M; Delva R; Krakowski I; Laguerre B; Théodore C; Ferrero JM; Beuzeboc P; Habibian M; Rolland F; Deplanque G; Pouessel D; Zanetta S; Berdah JF; Dauba J; Baciuchka M; Platini C; Linassier C; Tubiana-Mathieu N; Machiels JP; Kouri CE; Ravaud A; Suc E; Eymard JC; Hasbini A; Bousquet G; Culine S; Boher JM; Tergemina-Clain G; Legoupil C; Fizazi K
    Eur Urol; 2018 May; 73(5):696-703. PubMed ID: 29074061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility and safety of physical exercise in men with prostate cancer receiving androgen deprivation therapy and radiotherapy: a study protocol.
    Bressi B; Iotti C; Cagliari M; Cavuto S; Fugazzaro S; Costi S
    BMJ Open; 2022 Mar; 12(3):e048854. PubMed ID: 35292485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of delivering supervised exercise training following surgical resection and during adjuvant chemotherapy for pancreatic ductal adenocarcinoma (PRECISE): a case series.
    Brown M; O'Connor D; Turkington R; Eatock M; Vince R; Hulme C; Bowdery R; Robinson R; Wadsley J; Maraveyas A; Prue G
    BMC Sports Sci Med Rehabil; 2023 Sep; 15(1):116. PubMed ID: 37735664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.